key: cord-0965670-i8kwhhwt authors: Yang, Fan; Shi, Shaobo; Zhu, Jiling; Shi, Jinzhi; Dai, Kai; Chen, Xiaobei title: Analysis of 92 deceased patients with COVID‐19 date: 2020-04-15 journal: J Med Virol DOI: 10.1002/jmv.25891 sha: 05ce03b9618901743207fbc88de0392b7013e410 doc_id: 965670 cord_uid: i8kwhhwt OBJECTIVE: This retrospective study aimed to analysis the clinical characteristics and complications in death cases with novel coronavirus disease‐19 (COVID‐19). METHOD: We collected the medical records of 92 patients with COVID‐19 in Renmin Hospital of Wuhan University who died during January 6th to February 25th, 2020, summarized the clinical characteristics of complications. RESULTS: There were 91 death cases who developed different complications including acute respiratory distress syndrome (ARDS) (73/91), myocardial injury (31/91), liver injury (15/91), renal insufficiency (14/91), multiple organ dysfunction syndrome (MODS) (14/91) and pneumothorax (1/91). Among these patients, 83 patients had at least one complication. While 1 patient who died of recurrent gastrointestinal bleeding was not directly linked to COVID‐19. CONCLUSION: The main complications of deceased patients with COVID‐19 were ARDS, myocardial injury, liver injury, renal insufficiency and MODS. This article is protected by copyright. All rights reserved. Since December 2019, there had been an outbreak of a novel coronavirus disease in Wuhan, China. The coronavirus had been named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) currently, which has a phylogenetic similarity to SARS-CoV 1 . Patients with COVID-19 have been documented both in hospitals and in community. There have been confirmed 81865 cases of COVID-19, including 3335 death cases by April 8 th . The average mortality rate was about 4.07% 2 . The common clinical manifestations were fever, dry cough, fatigue, myalgia, dyspnea, normal or decreased leukocyte counts and radiographic evidence of pneumonia. Severe cases were prone to suffer various complications, especially death cases 3, 4, 5, 6 . To illustrate the clinical characteristics of complications, we collected medical records of 92 deceased patients with COVID-19. There were 92 cases with COVID-19 were enrolled in Renmin Hospital of Wuhan University who died during Jan 6th to Feb 25th, 2020. All patients were laboratoryconfirmed positives of SARS-CoV-2 by quantitative RT-PCR (qRT-PCR) on nasopharynx swab samples. Diagnosis of COVID-19 was based on the New Coronavirus Pneumonia Prevention and Control Program (3th edition) published by the National Health Commission of China 7 .The study was approved by the Institutional Ethics Committee of Renmin Hospital of Wuhan University. The information of patients who died of COVID-19 were collected including medical records, laboratory results and computed tomography. All information was obtained and curated with a customized data collection form. Two investigators independently reviewed the data collection forms to verify data accuracy. Complication was defined as a dangerous disease or condition arising from COVID-19.ARDS was diagnosed according to the Berlin definition 8 .Cause of death generally means condition or diseases lead to death directly. Statistical analysis was done with SPSS, version 20.0. The results were expressed as means ±SD or median (IQR). Student's t test was performed to examine the differences between groups. P value less than 0.05 was considered statistically significant. As shown in Table 1 , the average age of 92 patients was 69.8 ± 14.5 years, range from 30 to 97 years, including 49 males and 43 females. The mean survival time from the onset of symptoms to death was 14.3 ± 6.0 days. 91 cases represented with at least one complication including ARDS (73/91), myocardial injury (31/91), liver injury (15/91), renal injury (14/91), MODS (14/91), and pneumothorax (1/91). In addition, there was one patient who died of recurrent esophageal varices from cirrhosis, indirectly related to COVID-19. There were 65 cases had underlying diseases, which were hypertension (51/92), heart disease (16/92), diabetes (13/92), cerebrovascular disease (10/92), malignancy (4/92), chronic liver diseases (3/92), chronic renal insufficiency (2/92), hematological system disease (2/92) and chronic obstructive pulmonary disease (1/92) ( Table 1) . The causes of death in patients with COVID-19 were ARDS (73/92), septic shock (7/92), myocardial infarction (6/92), heart failure (2/92), MODS (2/92), esophageal varices (1/92), and pneumothorax (1/92) ( Table 1) . The main death cause of COVID-19 in this study was ARDS (73/92). There was one patient who had fever for 3 days, died of pneumothorax in day5 of hospitalization. The inflammatory markers including procalcitonin (PCT), C-reactive protein (CRP) and Serum amyloid A (SAA) were investigated in this study. During hospitalization, there were 39 cases had a high level of inflammatory markers. 28 cases showed a high level of PCT (>10-fold), 34 cases had a high level of CRP (>5-fold), and 30 cases had a high level of SAA (above 300mg/L). Median levels of PCT, CRP and SAA in patients with inflammation state were 1.80ng/mL (p<0.05), 148.0mg/L (p<0.01) and 300.0 mg/L (p<0.01), respectively, compared with patients without inflammation state (shown in Table 2 ) There were 31 patients had increased myocardial enzymes during hospitalization. 31 cases had abnormal cardiac troponin I (cTnI) (upper limited unit (ULN) < 0.04ng/ml), 24 cases of them were much higher than 0.78ng/ml which means obvious myocardial injury. In addition to cTnI, creatine kinase MB (CK-MB) and myoglobin (Mb) also increased. In cases with myocardial injury, the median levels of cTnI (p<0.05), CK-MB (p>0.05) and Mb (p<0.05) were 2.47ng/mL, 6.8ng/mL and 629.0μg/L, respectively, compared with cases without myocardial injury (shown in Table 2 ). There were 15 cases experienced liver injury in our study. 10 cases had elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) exceeding 3 times of ULN, and 4 cases had increased total bilirubin (TBIL) (exceeding 3 times of ULN). The highest TBIL of 92 patients was 439 μmol/L. The median levels of ALT, AST and TBIL in patients with liver injury were 117 U/L (p>0.05), 157 U/L (p>0.05) and 47.0μmol/L (p<0.05) ( Table 2) respectively, compared with patients without liver injury. We had also collected the level of albumin, the average albumin of 92 patients with COVID-19 was 31.1±4.4 g/L(data not showed), lower than upper limited unit(ULN>35g/L). There were 14 patients suffered renal injury after infection of SARS-CoV-2. None of them had chronic renal insufficiency. 7 patients were found with elevated serum creatinine (SCr) at admission. While there were another 7 cases with normal SCr at beginning, had an increased level of SCr at the second test, accompanied by a decrease in glomerular filtration rate (GFR). The median levels of SCr, BUN and GFR in cases with renal insufficiency were 262μmol/L (p<0.01), 30.0mmol/L (p<0.01), 18.0mL/min (p<0.01), respectively, compared with the cases without renal injury (shown in Table 2 ). There were 14 patients had multiple organ dysfunction syndrome (MODS). Among them, PCT increased significantly in 12 cases, suggesting a possible infection, and 4 cases were associated with myocardial injury. The most common complication was ARDS (73/92) in COVID-19, which was similar to SARS outbroken in 2003 9, 10 . Histological examination of death case showed that bilateral diffuse alveolar damage with cellular fibromyxoid exudates were found. Evident desquamation of pneumocytes and hyaline membrane formation indicated acute respiratory distress syndrome 11 . Similar to the SARS, after heavy inflammation lesions of lung, some patients progressed to pulmonary fibrosis, which may affect lung function in the long-term, especially in old age 12 . It was reported that cardiovascular complications were common in patients with SARS 13 . 31 cases had obvious myocardial damage with increased cardiac troponin obviously in our study. The median levels of cTnI and Mb in cases with myocardial injury increased significantly compared with the patients without myocardial injury. There were 6 cases were diagnosed as myocardial infarction which was fatal. The potential mechanism for COVID-19 caused myocardial injury might be virus induced cytokine storm. Inflammatory cells infiltration and inflammatory cytokines release can directly lead to apoptosis or necrosis of myocardial cells 14, 15 . The inflammatory markers (PCT, CRP and SAA) elevated frequently in patients with COVID-19. The median levels of PCT, CRP and SAA increased significantly in cases with inflammation state. It suggested the pathogenesis of COVID-19 is related to systemic inflammatory response syndrome (SIRS) which may result to MODS 16, 17 . Studies have shown that cytokine storms are associated with the exacerbation of a variety of infectious diseases, including Severe Acute Respiratory Syndrome and avian influenza 18, 19 . Some related clinical data also suggest that cytokine storm could be associated with disease severity 20, 21 .Therefore, controlling the overt inflammatory response induced by COVID-19 may be essential for reducing mortality among critically ill patients with COVID-19 22, 23 . According to guideline, low dose (1-2mg/kg weight) of corticosteroids had been used for 3-5days to reduce inflammation 7 . However, corticosteroids may not only inhibit the immune system but also increase the chance of secondary bacterial infection and viral shedding period, so it is still a controversial. It showed more than 60% of SARS patients had liver damage 24 , and patients infected with MERS-CoV also experienced liver injury 25 . There were 15 cases showed liver injury in this study, similar to other reports 26, 27 , pathology study confirmed presence of virus in liver tissue of patients with SARS, but no virus inclusion bodies were detected 27 , which was similar to autopsy of COVID-19 28 . A preliminary study showed that the SARS-CoV-2 receptor ACE2 was highly expressed in bile duct cells 29 , suggesting that SARS-CoV-2 may directly bind to ACE2-positive bile duct cells, and lead to liver dysfunction. It showed that liver injury associated with COVID-19 may also be due to drug hepatotoxicity, in addition, immune mediated inflammation, such as cytokine storms, may also lead to liver damage 27 . Also liver injury and malnutrition may lead to hypoalbuminemia. There were 14 patients suffered renal insufficiency in this study. The median levels of SCr, BUN and GFR in patients with renal injury, showed statistical significances compared with the cases without renal injury. Researchers reported that ACE-2 receptor of SARS-CoV was highly expressed in renal tubules 30, 31 , and recent study indicated that they demonstrated the SARS-CoV-2 virus can directly infect human renal tubules and consequently lead to acute renal tubular injury 32 . It suggests the infection of SARS-CoV may damage human renal tubules through the ACE-2 receptor. However, it needs more clinical data to interpret. In summary, as an emerging infectious disease, the infection of SARS-CoV-2 were multi-organ involved. ARDS had the highest incidence and was the most common cause of death. In addition, damages to myocardial cells, liver and renal had been observed in patients with COVID-19. Among critical patients, old age (>60 years), underlying diseases and multi organ involved were common characteristics. Oxygen A novel coronavirus from patients with pneumonia in China National Health Commission of the People's Republic of China home page A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Importation and human-to-human transmission of a novel coronavirus in Vietnam Transmission of 2019-nCoV infection from an asymptomatic contact in Germany Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Guideline for Diagnosis and Treatment of Novel Coronavirus-infected Pneumonia (Trial version 3) Acute respiratory distress syndrome: The Berlin definition The clinical pathology of severe acute respiratory syndrome (SARS): a report from China Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates Associated With Acute Respiratory Distress Syndrome Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience Cardiovascular complications of severe acute respiratory syndrome CaMKII is a RIP3 substrate mediating ischemia-and oxidative stress-induced myocardial necroptosis Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) systemic inflammatory response, and multiple organ dysfunction: the mystery continues An interferon-gamma-related cytokine storm in SARS patients Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque Clinical features of patients infected with 2019 novel coronavirus in Wuhan Aveolar Macrophage Activation and Cytokine Storm in the Pathogenesis of Severe COVID-19 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System. Engineering SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection-clinicopathological and ultrastructural study Clinical characteristics of Non-ICU hospitalized patients with coronavirus disease 2019 and liver injury：A Retrospective study Liver injury in COVID-19: management and challenges Pathological findings of COVID-19 associated with acute respiratory distress syndrome Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection N represents the number of patients included in the study. Complications were counted except one patient who died of recurrent gastrointestinal bleeding Data are presented as median (IQR), p values comparing abnormal and normal are from Student's t test. COVID-19=novel coronavirus disease-19.CRP=C-reactive protein. SAA=Serum amyloid A. PCT =procalcitonin. CK-MB=creatine kinase. Mb=myoglobin. cTnI=cardiac troponin I AST=aspartate aminotransferase. TBiL=total bilirubin. BUN=blood urea nitrogen. SCr=serum creatinine. GFR=glomerular filtration rate Not applicable. Chronic underlying disease (N=92 )